T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Lantronix
LTRX
$272M
| $140K | ﹤0.01% |
48,722
+27,722
| +132% | +$63K |
|
|
RZLV
2802
Rezolve AI
RZLV
$1.06B
| $140K | ﹤0.01% |
+45,576
| New | +$89.8K |
|
2803
Arteris
AIP
$1.36B
| $139K | ﹤0.01% |
14,498
+2,200
| +18% | +$16.2K |
|
2804
Entravision Communication
EVC
$820M
| $139K | ﹤0.01% |
59,813
-515
| -0.9% | -$1.04K |
|
2805
American Well
AMWL
$220M
| $138K | ﹤0.01% |
15,498
-407
| -3% | -$2.91K |
|
2806
Comtech Telecommunications
CMTL
$52.7M
| $138K | ﹤0.01% |
56,107
-836
| -1% | -$1.5K |
|
|
IRBT
2807
DELISTED
iRobot
IRBT
| $138K | ﹤0.01% |
43,940
-13,136
| -23% | -$36.3K |
|
|
MPX
2808
DELISTED
Marine Products Corp
MPX
| $138K | ﹤0.01% |
16,155
+1,487
| +10% | +$12.4K |
|
2809
Ranpak Holdings
PACK
$479M
| $138K | ﹤0.01% |
38,584
+2,298
| +6% | +$8.52K |
|
2810
Paysign
PAYS
$735M
| $137K | ﹤0.01% |
18,928
+4,328
| +30% | +$15.5K |
|
2811
Mama's Creations
MAMA
$790M
| $135K | ﹤0.01% |
16,245
+1,940
| +14% | +$14K |
|
2812
Neuropace
NPCE
$498M
| $135K | ﹤0.01% |
+12,058
| New | +$151K |
|
2813
Altimmune
ALT
$560M
| $133K | ﹤0.01% |
34,231
+2,753
| +9% | +$14.9K |
|
2814
Senseonics Holdings Inc
SENS
$409M
| $133K | ﹤0.01% |
14,076
-369
| -3% | -$4.3K |
|
|
PHLT
2815
DELISTED
Performant Healthcare Inc
PHLT
| $133K | ﹤0.01% |
33,248
+3,513
| +12% | +$9.96K |
|
|
ESPR
2816
DELISTED
Esperion Therapeutics
ESPR
| $132K | ﹤0.01% |
134,514
+8,961
| +7% | +$8.97K |
|
2817
4D Molecular Therapeutics
FDMT
$609M
| $132K | ﹤0.01% |
35,328
+8,800
| +33% | +$30.9K |
|
2818
Humacyte
HUMA
$148M
| $132K | ﹤0.01% |
62,842
+25,252
| +67% | +$48.5K |
|
2819
Treace Medical Concepts
TMCI
$293M
| $131K | ﹤0.01% |
22,117
+1,118
| +5% | +$7.28K |
|
2820
Alto Neuroscience
ANRO
$1.26B
| $131K | ﹤0.01% |
59,428
+5,499
| +10% | +$13.1K |
|
2821
Fossil Group
FOSL
$330M
| $129K | ﹤0.01% |
86,628
-2,272
| -3% | -$2.86K |
|
2822
Neuronetics
STIM
$211M
| $129K | ﹤0.01% |
36,861
+17,761
| +93% | +$70.1K |
|
2823
DocGo
DCGO
$64.5M
| $128K | ﹤0.01% |
81,037
+4,420
| +6% | +$8.24K |
|
2824
Olema Pharmaceuticals
OLMA
$920M
| $128K | ﹤0.01% |
29,861
+12,325
| +70% | +$55K |
|
2825
Century Casinos
CNTY
$35.2M
| $127K | ﹤0.01% |
59,831
-1,569
| -3% | -$2.8K |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.